True Ventures

True Ventures positions itself as a conviction‑driven, first‑money investor at the earliest stages, explicitly stating it leads early rounds into founders "building the future." The firm’s core values put people first and encourage taking big swings: "Consensus is lame. Conviction is rare… We don’t want safe bets." Their public "Pitch Us" guidance reinforces an open, founder‑centric lens: "The earlier, the better," "The weirder, the better," and a preference for high‑EQ founders who share True’s values and can operate in uncertain, emergent markets. Platform‑wise, they have built a two‑decade founder community with high trust and mutual support, offering regular programming and resources under the True Platform. Sectorally, True’s recent stance is to "accelerate AI‑native founders at the earliest stages," while their portfolio filters show activity across AI, B2B software, infrastructure, security, bio/health, climate, hardware/robotics, and consumer. Their 2020 fund announcement also cited technology‑enabled consumer brands, SaaS and infrastructure software, and deep verticals in health and life sciences as core markets. Historically, True has backed category‑defining consumer platforms and frontier tech (e.g., Fitbit, Ring, Peloton; MakerBot; ICEYE). Geographically, True’s offices are in San Francisco and Palo Alto, but selective international bets (e.g., ICEYE in Finland; Team‑GPT in Bulgaria) indicate a primarily U.S. orientation with occasional non‑U.S. investments when founder/market fit is compelling. The firm maintains Select vehicles for follow‑on into breakouts, enabling multi‑stage support from first check to scale. Overall, the thesis centers on backing extraordinary founders in nascent or newly possible markets (often tech‑driven shifts such as genAI) and supporting them deeply with capital, community, and conviction from day zero.

• Duo SecurityLead
  Seed‑stage security platform backed as the first investor, fitting True's "first‑to‑believe" approach in high‑growth B2B software.
• ICEYELead
  Deep‑tech satellite imaging startup where True led the Series A, aligning with the firm’s willingness to lead early in ambitious hardware‑data markets.
• Enveda BiosciencesLead
  AI‑driven drug discovery company led at seed, matching True’s AI‑native and biotech thesis.
• TenkaraLead
  AI agents for manufacturing operations led at a $7 M round, exemplifying the firm’s focus on founder‑first AI solutions for frontier industries.
• HashiCorp
  Iconic developer‑infrastructure platform where True was an early seed investor, fitting the firm’s early‑stage software focus even though it did not lead.
• Peloton
  Consumer‑hardware brand entered through a "special opportunity" investment, reflecting True’s selective participation in breakout consumer businesses.
• Handshake
  B2B talent marketplace where True participated early, aligning with its interest in platforms that address large market problems.
• Fitbit
  Connected‑health wearables backed early, consistent with True’s history of supporting consumer‑hardware founders.
• Veza
  Data‑security platform receiving a first seed check, fitting True’s security and AI‑native thesis.

• 
  Notable Capital

  HandshakeHashiCorp
• 
  Mayfield Fund

  HashiCorp